Trials / Active Not Recruiting
Active Not RecruitingNCT04679376
Statins for the Treatment of NASH
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Statins in Adult Patients With Non-Alcoholic Steatohepatitis (NASH)
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to determine whether the study drug, atorvastatin (Lipitor®), is safe and effective in improving the features of NASH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | 40 mg daily administered orally in tablet or capsule form |
| DRUG | Placebo | Administered daily orally in tablet or capsule form, contains no active medicine |
Timeline
- Start date
- 2023-01-25
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2020-12-22
- Last updated
- 2026-01-20
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04679376. Inclusion in this directory is not an endorsement.